High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)

BACKGROUND: Patients with stable coronary artery disease on single-antiplatelet therapy with aspirin are still at risk for atherothrombotic events, and high on-aspirin residual platelet reactivity (RPR) has been suggested as a risk factor. METHODS AND RESULTS: In this randomized trial, the associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettersen, Alf-Åge R., Seljeflot, Ingebjørg, Abdelnoor, Michael, Arnesen, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487336/
https://www.ncbi.nlm.nih.gov/pubmed/23130135
http://dx.doi.org/10.1161/JAHA.112.000703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487336/
https://www.ncbi.nlm.nih.gov/pubmed/23130135
http://dx.doi.org/10.1161/JAHA.112.000703

Ejemplares similares